The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
The Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 56.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.94 | 4.8 Bil | Healthcare |
UnitedHealth Group Inc | 9.38 | 3.8 Bil | Healthcare |
Johnson & Johnson | 6.99 | 2.8 Bil | Healthcare |
AbbVie Inc | 5.86 | 2.4 Bil | Healthcare |
Merck & Co Inc | 5.80 | 2.3 Bil | Healthcare |
Thermo Fisher Scientific Inc | 4.13 | 1.7 Bil | Healthcare |
Abbott Laboratories | 3.36 | 1.4 Bil | Healthcare |
Amgen Inc | 3.26 | 1.3 Bil | Healthcare |
Danaher Corp | 3.24 | 1.3 Bil | Healthcare |
Pfizer Inc | 3.11 | 1.3 Bil | Healthcare |